Willems, Damon http://orcid.org/0000-0001-8263-4047
Hiligsmann, Mickael http://orcid.org/0000-0003-4274-9258
van der Zee, Hessel H
Sayed, Christopher J
Evers, Silvia M A A http://orcid.org/0000-0003-1026-570X
Article History
Accepted: 15 July 2021
First Online: 9 August 2021
Declarations
:
: No funding was received for the conduct of this study.
: DW is a registered PhD student at Maastricht University and an employee of UCB Pharma, UCB Pharma had no role in the design, conduct, and analysis of the study, or in the writing/reviewing of this manuscript. All other authors declare no conflict of interest for the conduct and presentation of this research, but HvZ declares to have received consultancy fees from AbbVie, InflaRx, and Novartis and CS declares to have received honoraria paid to an institution as an investigator for AbbVie, Chemocentryx, Incyte, InflaRx, Novartis, and UCB Pharma; consultancy fees from AbbVie and InflaRx; speaking fees for AbbVie and Novartis; and consulting fees paid to an institution from UCB Pharma.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of Maastricht University and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: The submission does not include personal details or images that may lead to the identification of participants and all participants gave consent to publish their anonymized data.
: Not applicable.
: Not applicable.
: All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by all authors. The manuscript was written by DW and all authors provided feedback throughout the development of the manuscript. All authors read and approved the final manuscript. All authors sufficiently contributed to this research according to ICMJE criteria to qualify as a listed author.